18h
Stockhead on MSNDimerix banks initial $3.2m payment in Japanese pharma licensing deal for kidney drugSpecial Report: Dimerix has received the initial payment of ¥300 million (A$3.2 million) in line with its recently announced ...
Dimerix Ltd (ASX:DXB) has confirmed its receipt of its first $3.2 million payment from Japan’s FUSO Pharmaceutical Industries ...
Healthcare analysts believe that shares in rare neurological share play Neuren Pharmaceuticals are well undervalued after a ...
Index fell 7.66% in February to be the second-worst performing sector for the month as the local bourse felt the pressure of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results